Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
4/8/2024
Boehringer Ingelheim and Sino Biopharm Enter Strategic Deal to Develop...
4/5/2024
Recent Official Changes and Executive Moves
4/5/2024
Drug R&D and Product Registration News Digest April 2024 (1)
4/5/2024
UB and 7th Affiliated Hospital of SYU Launch A Joint Clinical Research...
4/5/2024
China Continues to Crackdown on Monopoly and Unfair Market Practices i...
4/5/2024
Ascletis Drops FXR Agonist ASC42 After Disappointing Phase II Results
4/4/2024
Rohto and Mitsui to Buy TCM Company for $590M
4/3/2024
NMPA Issues the Principles and Procedures for Exploratory Studies of D...
4/3/2024
NMPA Issues Announcement on the Implementation of Electronic Drug Regi...
4/3/2024
Genmab A/S to Acquire ADC Developer ProfoundBio for $1.8B Cash
4/2/2024
Takeda's Drive: Elevating Chinese Clinical Trials and Global Health
4/2/2024
Aurisco Launches State-of-the-Art Manufacturing Facility for GLP-1 Pep...
4/2/2024
CDE Solicits Comments on the Pharmaceutical Self-Assessment Report for...
4/2/2024
NHC Holds the 2024 National Drug Administration Work Conference
4/1/2024
CMS and Incyte Enter License Deal for Povorcitinib in China and SE Asi...
4/1/2024
Congress Targets Biotech Suppliers for Pentagon Watchlist Amid China S...
4/1/2024
CDE Solicits Comments on the Technical Guidelines for Clinical Trial D...
4/1/2024
NMPA Announces Package Insert Revision of Metronidazole Injection and ...
3/30/2024
NMPA Holds the 2024 National Drug Regulatory Policy and Regulation Wor...
3/30/2024
Recent Official Changes and Executive Moves
3/30/2024
Financial-related Company News Digest (March 2024)
3/30/2024
Drug R&D and Product Registration News Digest March 2024 (4)
3/30/2024
JPO Launches Follow-On Procurement for the National Level Insulin VBP ...
3/27/2024
Mitsui & Rohto-led Consortium Near Deal to Acquire Eu Yan Sang
3/27/2024
China's Primary Healthcare Institutions Handle Over Half of Total Medi...
3/27/2024
Oncology Partnerships in China Account for 41% of All Deals Over Past ...
3/27/2024
NMPA Holds National Conference on Drug Registration and Post-Market Re...
3/27/2024
NIFDC Issues the 2023 National Drug Sample Inspection Annual Report
3/27/2024
AstraZeneca Plans to Divide Drug Production between US and China Amid ...
3/26/2024
AZ and Pfizer CEOs Pledge Support for China's Biopharma Industry Growt...
Page:
34
/
41
Total number of articles:
1204
:
[First]
[<<]
[32]
[33]
[34]
[35]
[36]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit